Gerardo Fernandez Email

Chief Scientific Officer and Founder . PreciseDx

Current Roles

Employees:
23
Revenue:
$1.7M
About
PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology features, enabling better and more personalized treatment and outcomes. Clinical teams can rely on PreciseDx for unmatched insights and actionable intelligence in determining the best treatment for each patient.
PreciseDx Address
1 Gustave L Levy Place
New York, NY
PreciseDx Email

Past Companies

PreciseDxChief Scientific Officer and Founder
Icahn School of Medicine at Mount SinaiAdjunct Associate Professor, Dept of Pathology, Icahn School of Medicine
Icahn School of Medicine at Mount Sinai HospitalAssociate Professor, Department of Pathology and Medical Director Precise MD

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.